We are pleased to announce details of our next BioTuesday on 21 February, supported by Venner Shipley​ and hosted by FTI Consulting​, that will be spotlighting the:

'Latest Research and Innovation In Cell & Gene Therapy'

The Cell and Gene Therapy sectors are growing exponentially, with much progress being made both in and out of the lab. After many decades of work, the impact of cell and gene therapies continues to be significant, with a number of recent successes leading to approval of several life-saving treatments for patients.

During the evening, we will hear from some key thoughtleaders who will share a broad update on the latest research as well as a series of showcase presentations from some of the most exciting innovators in the cell & gene therapy space.

After the panel discussion, there will be the opportunity to network with guests over drinks and nibbles.

Programme

17.30 – 18.00 Delegate Registration & Networking

18.00 – 18.10 Welcome and Introductions by OBN and Venner Shipley

18.10 – 18.50 Keynote Presentation from:

• Professor Amin Hajitou, Chair of Targeted Therapeutics, Imperial College London

18.50 – 19.40 Company showcase presentations from:

• Maavrx Ltd
• Oribiotech​
• eXmoor pharma​
• Laverock Therapeutics​
• ATZ Therapeutics
• Further companies to be announced soon

19.40 – 19.50 Audience Q&A

19.50 – 21.00 Networking Drinks Reception

21.00 - Event Close